Web2 apr. 2013 · With this approach, elderly patients with DLBCL treated with a curative intent can reach a complete remission and have a similar outcome as younger patients. … Web20 apr. 2024 · Purpose The standard treatment of patients with diffuse large B-cell lymphoma (DLBCL) is rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Lenalidomide, an immunomodulatory agent, has shown activity in DLBCL. This randomized phase III trial compared lenalidomide as …
Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches
Web2 apr. 2024 · A simplified geriatric assessment offers a validated objective tool to assess fitness status and should be considered the new Elderly Prognostic Index (EPI) standard … WebAs subtype-specific treatment options begin to emerge, advanced molecular testing will gain importance regardless of patient age to help identify the most efficacious thera … csp taunton
Diffuse large B-cell lymphoma: new targets and novel therapies
Web17 mei 2024 · Initial treatment of DLBCL is determined by the disease stage ( table 1 ). For treatment purposes, patients with DLBCL are generally classified as having either … Web9 mrt. 2024 · Thus, there are two key knowledge gaps for elderly patients with DLBCL: (1) identifying the optimal treatment regimen that will cure as many patients as possible … Web3 jan. 2024 · Selinexor. In 2024, selinexor was approved by the FDA for use in adult patients with R/R DLBCL (including follicular lymphoma-derived DLBCL) after at least 2 … eamonn maxwell arts council